IP Library Granted Patent US 9,232,960
Granted Patent B2
US 9,232,960 · App. 13/790,218 · Granted Jan 12, 2016

Minimally invasive devices for multi-fluid tissue ablation

Inventors: Nikolai Aljuri (Hillsborough, CA); George Surjan (Redwood City, CA)
Assignee: AQUABEAM, LLC
A61B17/3203A61B17/32037A61B18/04A61B18/14A61B18/1485A61B18/18A61B18/201A61B18/24A61F9/007A61B2018/00196A61B2018/00285A61B2018/00547A61B2018/00577A61B2018/00583A61B2018/00946A61B2018/00952A61B2018/046A61B2018/1472A61B2018/1497A61B2018/1861A61B2218/002A61B2218/007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,232,960
App. No.
13/790,218
Granted
Jan 12, 2016
Kind
B2
Abstract

Prostate treatment using fluid stream to resect prostate tissue, thereby relieving symptoms of conditions such as BPH, prostatitis, and prostatic carcinoma. A device having a fluid delivery element is positioned within a lumen of the urethra within the prostate. A fluid stream is directed outwardly from the fluid delivery element toward a wall of the urethral lumen. The fluid delivery element is moved to scan the fluid stream over the wall to remove a volume of tissue surrounding the lumen. The fluid may be combined with therapeutically active substances or with substances that increase resection efficiency. Fluid force may be adjusted to provide selective tissue resection such that soft tissue is removed while harder tissue is left undamaged. In order to gain a working space within the urethra, another fluid may be introduced to insufflate the urethra in the region of treatment.

Claims (20)

1. A tissue modification device, comprising: an elongate element having a proximal end and a distal end, wherein the elongate element is configured to be inserted into an organ; a first lumen in the elongate element configured to deliver a first fluid into the organ to create a working space; a fluid delivery element disposed within the elongate element, wherein the fluid delivery element is configured to discharge a second fluid as a fluid stream to resect a volume of tissue with the working space; and a second lumen in the elongate element for evacuating tissue resected with the fluid delivery element in order to remove resected products.

2. The device of claim 1 , wherein the device is configured to deliver the first fluid until a pressure within the working space is in a 0.1 psi to 5 psi range.

3. The device of claim 1 , wherein the device is configured to deliver the fluid stream with a fluid stream shape and fluid stream source pressure chosen to selectively resect the tissue.

4. The device of claim 1 , wherein the fluid delivery element is configured to translate, rotate, oscillate, or rotationally oscillate relative to the elongate element.

5. The device as in claim 1 , wherein the device is configured to deliver a sufficient amount of the first fluid to create a volume of the first fluid within the working space, such that the fluid stream travels through the volume of the first fluid.

6. The device of claim 5 , wherein the first fluid is a gas and the second fluid is a liquid.

7. The device of claim 6 , wherein the gas is delivered and envelopes the resection liquid fluid stream to maintain the integrity of the liquid fluid stream.

8. The device of claim 5 , further comprising a visualization element disposed within the elongate element and configured to visualize the tissue.

9. The device of claim 1 , further comprising an energy conduit configured to transmit energy through an interior of the fluid stream to cauterize the tissue.

10. The device of claim 8 , wherein the device is configured to decrease the fluid stream force to a level that is sufficient to transmit the energy but insufficient to resect the tissue.

11. The device of claim 10 , wherein the device is further configured to resect the tissue using the energy transmitted through the interior of the fluid stream.

12. The device of claim 9 , wherein the energy is electromagnetic energy.

13. The device of claim 12 , wherein the electromagnetic energy is light.

14. The device of claim 12 , wherein the electromagnetic energy is radiofrequency energy.

15. The device of claim 1 , further comprising an expandable anchor near the distal end of the elongate element, wherein the expandable anchor is configured to stabilize the elongate element during resection.

16. The device of claim 15 , wherein the tissue is prostate tissue and the anchor is configured to expand within a bladder.

17. The device of claim 1 , wherein the device is configured to maintain a pressure differential between the first lumen and the second lumen to evacuate resected products through the second lumen.

18. The device of claim 1 , wherein the first lumen is configured to direct the first fluid towards the fluid delivery element, thereby maintaining the integrity of the fluid stream.

19. The device of claim 1 , wherein the second fluid is different from the first fluid.

20. The device of claim 1 , wherein the second fluid is similar to the first fluid.

Assignments (3)
SECURITY INTEREST Recorded Oct 6, 2022
From: PROCEPT BIOROBOTICS CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 061623/0289 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2013
From: PROCEPT CORPORATION
To: AQUABEAM, LLC
Reel/Frame 030719/0071 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2013
From: ALJURI, NIKOLAI; SURJAN, GEORGE
To: PROCEPT BIOROBOTICS CORPORATION
Reel/Frame 030703/0468 →
Continuity (7)
Division 12700568 · Feb 4, 2010
Continuation In Part 11968445 · Jan 2, 2008
Continuation In Part 12399585 · Mar 6, 2009
Provisional Application 60883097 · Jan 2, 2007
Provisional Application 61097497 · Sep 16, 2008
Provisional Application 61034412 · Mar 6, 2008
Related Publication 20130253488A1 · Sep 26, 2013